Reliable Business Intelligence News About Clinical Laboratories, Pathology Groups, & Laboratory
Diagnostics Since 1995

Subscriber?

Issues Archive

The most complete archive of clinical and pathology lab industry news available, including issues from 1997 to the present.

Volume XXV No. 15 – October 22, 2018

In this issue:

WHO WILL BE NEXT? As federal prosecutors indicate in court there’s more to come in the ongoing Theranos investigation, that leaves the lab industry wondering who else might be charged with crimes. Reported only in THE DARK REPORT, this development means that any number of people could be targeted: former members of the Board of Directors, various consultants, even vendors. Meanwhile, Medicare has begun publicly posting prices charged by every pathologist in the country — so that every one of them can find out what their competition is up to. Will a new price war result? THE DARK REPORT offers a pricing “sweet spot” for readers to consider.

View Issue TOC


Volume XXV No. 14 – October 1, 2018

In this issue:

TWO FEDERAL COURT RULINGS that will have immediate impact on the clinical lab industry are analyzed in detail in this issue. In a major setback for the ACLA lawsuit against the federal Department of Health and Human Services, a judge has ruled that the court lacks jurisdiction to take the case. THE DARK REPORT also offers an exclusive interview with the ACLA’s lead attorney to help readers understand the issues surrounding a possible appeal. Also exclusive to THE DARK REPORT is a report about a court ruling that two fairly common lab business practices are illegal inducements.

View Issue TOC


Volume XXV No. 13 – September 10, 2018

In this issue:

CLINICAL LABORATORY MANAGERS will learn in this issue about two trends that are driving a movement to standardize laboratory operations across large regions: the integration of clinical care and the need for hospitals and health networks to improve patient outcomes continuously. THE DARK REPORT dives deeply into the details of an ambitious program along these lines in Michigan. Also, Theranos’ dying breath is detailed as the once-vaunted company finally goes under.

View Issue TOC


Volume XXV No. 12 – August 20, 2018

In this issue:

THE DARK REPORT HAS UNCOVERED a previously unnoticed trend that turns common wisdom on Wall Street upside down: Hospitals and health systems may be taking back control of their their laboratory outreach programs instead of selling them, and committing major resources to their inpatient labs instead of outsourcing their management. TDR is the first to analyze this trend in three separate articles. Also, for both anatomical and clinical pathology, value-based payment is coming, creating an opening for pathologists who move quickly.

View Issue TOC


Volume XXV No. 11 – July 30, 2018

In this issue:

THE DARK REPORT DEMONSTRATES that CMS is once again seemingly ignoring Congress’ intent with the Protecting Access to Medicare Act (PAMA) by leaving out hospital labs and outreach laboratories from price reporting. What will the outcome be this time around? Also, only TDR has detected a potential opportunity in managed care contracting for regional and outreach labs that can demonstrate how they add value to patient care.

View Issue TOC


Volume XXV No. 10 – July 9, 2018

In this issue:

A CRISIS IN IRELAND has put two American laboratories in the crosshairs of potentially disastrous news reports, which, as THE DARK REPORT demonstrates, can quickly undermine the credibility – and profitability – of any lab. Also, THE DARK REPORT is first in the industry to call attention to new developments in the lab testing marketplace that have the potential to influence all clinical labs and pathology groups – in this case, the decision by two innovative health networks to make genetic tests available to their patients at primary care clinics.

View Issue TOC


Volume XXV No. 9 – June 18, 2018

In this issue:

THE DARK REPORT sums up a tale of two fraudsters: Two counts of conspiracy, nine counts of wire fraud, the possibility of a lifetime in prison and $2.75M in fines each for Theranos’ Elizabeth Holmes and Ramesh “Sunny” Balwani. What does it all mean for tech startups – and clinical labs? Also, this issue delivers specific strategies that lab outreach directors can use to overcome current challenges and protect revenue, increase market share, and contribute to better patient care.

View Issue TOC


Volume XXV No. 8 – May 29, 2018

In this issue:

THE DARK REPORT HAS DISCOVERED an intriguing but quiet trend in recent months: Lab companies are suddenly snatching up struggling rural hospitals to take advantage of their higher payment rates in what is called “pass-through billing,” a process that can and has strayed over the line into illegal territory. Interestingly, the businessman involved in one such recent transaction insists he “ran away as fast as possible” from an earlier company that was engaged in some sketchy billing schemes. Also in this issue, John Carreyrou of The Wall Street Journal describes his shocking experiences as he dug into, and later exposed, the now-infamous Theranos pyramid scheme.

View Issue TOC


Volume XXV No. 7 – May 7, 2018

In this issue:

THE FUTURE OF THE LAB INDUSTRY was outlined in detail at the most recent Executive War College: Despite the challenges ahead, there are also tantalizing opportunities – but enterprising labs must pursue them vigorously. This intriguing finding is supported by a Cleveland Clinic test utilization management project also reported in this issue. In an exclusive analysis, THE DARK REPORT shows how the lab’s seven-year effort has prevented 160,072 tests and saved more than $5 million, while also improving quality and patient safety, and enhancing patient care and experience.

View Issue TOC


Volume XXV No. 6 – April 16, 2018

In this issue:

THE DARK REPORT digs into the shocking path lab deficiencies found at Wake Forest Baptist Medical Center and discovers that labs with a single individual with critical compliance, training and oversight responsibilities could leave them in the same dangerous position. Also, analysis in this issue helps lab executives understand the issues in the PAMA lawsuit against HHS to better prepare them to educate their elected officials.

View Issue TOC


Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.

platinum_edition

Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

CURRENT ISSUE

Volume XXXIII, No. 4 – March 23, 2026

A federal court ruling has established a safe harbor for clinical labs when they run tests ordered by physicians. Lab leaders should examine this briefing for pitfalls. Also, it turns out that providers may be ordering inappropriate vitamin D tests, according to one expert.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Start My 14 Day Trial
Learn More

Need A Group Membership? Company Discounts are Available!

Get More Information Now!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Click Here to Sign Up

Topics

Visit The Dark Library
;